Targeting GCase therapy(Congruence)

N/A

Report date: 2024/05/13 10:59:15
NME

Base Information

Drug NameTargeting GCase therapy(Congruence)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-glucocerebrosidase modulators
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCongruence Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCongruence Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A